Mr Samuel Plintovic Czech Republic

Zentiva Group, a.s.
Head of Licensing & Partnerships, Zentiva 

Ms Magdalena Poznanski Germany

RIEMSER Pharma GmbH is a European specialty pharmaceutical company established in December 1992 with core competencies focused niche therapy areas with high unmet medical need.

RIEMSER markets its own product portfolio in numerous therapeutic areas including oncology, neurology, anti-infectives and dermatology.

RIEMSER is present with own affiliates in Germany, France and UK and is selling its products in > 60 countries worldwide through a network of trusted partners.

We are looking to strengthen our portfolio through licensing or acquisition.

Ms Magdalena Poznanski
Riemser Pharma GmbH
Business Development Manager 

Mr Sascha Raber Switzerland

Mergers & Acquisitions

We are a deal broker and M&A advisory boutique that is specializing in transactions in the corporate sector of the pharmaceutical and healthcare industry and the consumer goods industry.

We support our clients in

  • Purchase and sale of companies and participations
  • Purchase and sale of brands and product portfolios
  • Business cooperations

We carry out targeted searches for transaction opportunities worldwide and support our clients in all phases of the M&A process.

Due to our long experience in this field and our continuously updated network of more than 40,000 strategic and financial investors worldwide we are able to quickly identify suitable investors and/or targets and complete transactions discreetly and reliably.

Mr Sascha Raber
PMC Pharma Management Consultants GmbH
M&A Advisor 

Dr Marc Raber Switzerland

Mergers & Acquisitions

We are a deal broker and M&A advisory boutique that is specializing in transactions in the corporate sector of the pharmaceutical and healthcare industry and the consumer goods industry.

We support our clients in

  • Purchase and sale of companies and participations
  • Purchase and sale of brands and product portfolios
  • Business cooperations

We carry out targeted searches for transaction opportunities worldwide and support our clients in all phases of the M&A process.

Due to our long experience in this field and our continuously updated network of more than 40,000 strategic and financial investors worldwide we are able to quickly identify suitable investors and/or targets and complete transactions discreetly and reliably.

Dr Marc Raber
PMC Pharma Management Consultants GmbH
Managing Director 

Dr Nicolas Rachinel Switzerland

Galderma
Licensing Project Manager 

Ms Anam Raja Canada

Paladin Labs is a specialty pharmacetuical company that in-licenses and commercializes innovative drugs for the Canadian market.

Partnering objectives: In-licensing or acquiring innovative pharmaceutical products

Therapeutic Areas: All

Paladin Labs Inc.
Manager, Business Development 

Dr Dankwart Rauscher Germany

Recordati Pharma GmbH
Head of Licensing and Business Development 

Dr Amarjit Reahal United Kingdom

Mitsubishi Tanabe Pharma Europe Ltd
GM EU Operations 

Mr Enrique REMEZAL Spain

 Zaltanpharma is an Innovative pharmaceutical company

We are focus on specialist & hospital products

We offer:

 - Experience and proven sales results

- Support of icon Group, leading service company in the healthcare industry

- Presence in Europe and America

We are interested in:

 Prescription drugs to be promoted in our expertise areas:

- Cardiology

- Rheumatology

- Traumatology

- Psychiatry

- Neurology

- Pain/Musculoskeletal

- Gyneacology

- Urology

We are interested in MA to be launched, mature products and products to be acquired.

We are NOT interested in:

 Generics without any innovation in formulation or dosis

Food supplements

Nutraceuticals

Natural/homeopatic products

Branded products earlier than Phase III

Mr Enrique REMEZAL
ZALTANPHARMA LABORATORIOS S.L
LinkedIn logo CEO 

Mrs Claudia Rinaldi Italy

PETRONE GROUP is a privately-owned family company operating in the pharmaceutical, parapharmaceutical and health sector since 1965, with the main offices in Italy and branches in Spain, Singapore and Ireland.

The Group provides a wide range of warehousing, world-wide distribution services.

 Pharmaidea is a partner of excellence for pharmaceutical companies that want to increase their value in pharmacy retail market in Italy and Spain, through tailor-made  business models  through a multi-channel approach directed to different targets measurable by PharmaCo through shared KPIs.

Thanks to the Euromed division, our company ensures an efficient and timely distribution of authorized orphan drugs and unlicensed products on “order to cash” basis all over Europe in order to facilitate patients’ access to innovative drug treatments as early as possible.

We offer customized and full-integrated logistic services also for the management of “restricted and controlled” drugs and cold chain products. These services include the manufacture of primary and secondary packaging, warehouse storage, labelling and shipping, and product recall along with authorized destruction procedures (STM division).

Our company is also specialized in Global Comparator Sourcing and IMP Management for international clinical trials: Euromed Clinical Supply Services (Eclisse division) is GCP-compliant and provides IMP Production services in accordance with EU-GMP/CGMP legal requirements.

Our Group is listed in SPAIN (BCN Farma division) as Authorized to manage Medicamentos Especiales while in IRELAND we currently hold the GMP certification to Store unauthorized European and non- European drugs.

 

Website:
www.petrone.it
Petrone Group
LinkedIn logo Corporate Business Development